| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5912155 | Multiple Sclerosis and Related Disorders | 2016 | 8 Pages |
Abstract
Given that severe relapses adversely affect patient-reported fatigue and HRQoL, prevention of severe relapses should be an important therapeutic aim in the treatment of patients with MS.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Mathias Mäurer, Giancarlo Comi, Mark S. Freedman, Ludwig Kappos, Tomas P. Olsson, Jerry S. Wolinsky, Aaron E. Miller, Catherine Dive-Pouletty, Sylvie Bozzi, Paul W. O'Connor,